Theralase® will be hosting a conference call on March 19th at 11:00 am ET, which will include a presentation of the financial ...

Given the chatter that this is a gold-standard ingredient for hair growth, you may be super tempted to hit "add to cart" on ...

Sino-American biopharma Ascentage Pharma has announced that olverembatinib has been granted Breakthrough Therapy Designation ...

Ascentage Pharma’s olverembatinib gets China NMPA’s BTD to treat Philadelphia chromosome-positive acute lymphoblastic leukemia: Rockville Friday, March 7, 2025, 11:00 Hrs [IST ...

City work crews were observed dismantling a section of a dedicated bike lane along Massachusetts Avenue in Dorchester between South Bay Mall and Edward Everett Square on Monday, March 10, 2025. The ...

DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...

As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...

DelveInsight's "TAGRISSO Market Size, Forecast, and Market Insight Report" highlights the details around TAGRISSO, a kinase ...

By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the first China-approved ...

A Bowdoin Street restaurant is hoping to be one of several businesses selected to receive a full liquor license in an upcoming second round of awards as part of an official push to expand ...

The Global Metal Fabrication Equipment Market is valued at approximately USD 68.36 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of over 3.90% from 2024 to 2032.

TAGRISSO has become a standard treatment due to its strong efficacy in both first-line and adjuvant settings. The growing prevalence of EGFR mutations, a rise in lung cancer diagnoses, and broader ...